Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Cryopreserved human hepatocytes have been used to predict hepatic in-vivo clearance. Physiologically-based direct scaling methods generally underestimate human in-vivo hepatic clearance. Cryopreserved human hepatocytes were incubated in 100% serum and in serum-free medium to predict the in-vivo hepatic clearance of six compounds (phenazone (antipyrine), bosentan, mibefradil, midazolam, naloxone and oxazepam). Monte Carlo simulations were performed in an attempt to incorporate the variability and uncertainty in the measured parameters to the prediction of hepatic clearance. The intrinsic clearance (CLint) and the associated variability of the six compounds decreased in the presence of serum and the values were reproducible across donors. The predicted CLhep, in-vivo obtained with hepatocytes from donors incubated in serum was more accurate than the prediction obtained in the absence of serum. For example, the CLhep, in-vivo of mibefradil in donor GNG was 4.27 mL min−1 kg−1 in the presence of serum and 0.46 mL min−1 kg−1 in the absence of serum (4.88 mL min−1 kg−1 observed in-vivo). Using the results obtained in this study together with an extended data set (26 compounds), the clearance of 77% of the compounds was predicted within a 2-fold error in the absence of serum. In the presence of serum, 85% of the compounds were successfully predicted within a 2-fold error. In conclusion, cryopreserved human hepatocyte suspensions represented a convenient and predictive model to assess human drug clearance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
Brian Houston, J. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90520-7 · Cited by 925 · cited 1×
“Excellent reviews that cover all aspects of the in-vitro to in-vivo scaling procedure have been published (Houston 1994; Iwatsubo et al 1997).”
BackgroundPrediction of in vivo drug metabolism in the human liver from in vitro metabolism data
Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., & Sugiyama, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00184-2 · Cited by 479 · cited 1×
“Excellent reviews that cover all aspects of the in-vitro to in-vivo scaling procedure have been published (Houston 1994; Iwatsubo et al 1997).”
BackgroundLav??, T., Coassolo, P., & Reigner, B. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936030-00003 · Cited by 162 · cited 1×
“Although freshly isolated human hepatocytes have been shown to be a good model for the prediction of in-vivo metabolism in man (Lave et al 1999), cryopreserved human hepatocytes are becoming more widely used for routine screening (Li et al 1999a, b; Hewitt et al 2001; Naritomi et al 2003).”
BackgroundSelf-citationPrediction of Hepatic Metabolic Clearance: Comparison and Assessment of Prediction Models
Zuegge, J., Schneider, G., Coassolo, P., & Lav??, T. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140070-00006 · Cited by 92
Self-citationHepatocyte [3H]-palmitate uptake: effect of albumin surface charge modification
Burczynski, F. J., Wang, G. Q., Elmadhoun, B., She, Y. M., Roberts, M. S., & Standing, K. G. (2001) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y01-072 · Cited by 28
Albumin Binding and Hepatic Uptake: The Importance of Model Selection
Forker, E. L., & Luxon, B. A. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721038 · Cited by 22
Cited by
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citationHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
“Shibata et al. (2002) suggested that hepatocytes should be pooled to give an “average donor”, however, an advantage of single donor incubations is that clearance may be linked to enzyme characteristics, as was demonstrated with four of the six compounds tested by Blanchard et al. (2006).”
BackgroundMethodResultInfluentialSelf-citationInterconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487
Preclinical experimental models of drug metabolism and disposition in drug discovery and development
Zhang, D., Luo, G., Ding, X., & Lu, C. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.10.004 · Cited by 309
Groothuis, F. A., Heringa, M. B., Nicol, B., Hermens, J. L. M., Blaauboer, B. J., & Kramer, N. I. (2015) · Toxicology · doi:10.1016/j.tox.2013.08.012 · Cited by 267
Metadata
- Authors
- Blanchard, N., Hewitt, N. J., Silber, P., Jones, H., Coassolo, P., & Lave, T.
- Venue
- Journal of Pharmacy and Pharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-01
- Volume
- 58
- Issue
- 5
- Pages
- 633-641
- ISSN
- 0022-3573 (ISSN-L)
- 2042-7158
- OpenAlex
- W2033648918
- Cited by
- 64
- References
- 6
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations. https://app.cochat.ai/papers/10.1211/jpp.58.5.0008
- The paper
- Blanchard, N., Hewitt, N. J., Silber, P., Jones, H., Coassolo, P., & Lave, T. (2006). Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations. Journal of Pharmacy and Pharmacology. https://doi.org/10.1211/jpp.58.5.0008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.